First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report ; volume:21 ; number:1 ; day:2 ; month:3 ; year:2023 ; pages:1-4 ; date:12.2023
World journal of surgical oncology ; 21, Heft 1 (2.3.2023), 1-4, 12.2023
- Creator
-
Yang, Shuang
Feng, Weineng
Deng, Yanming
Liang, Jianmiao
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-023-02935-9
- URN
-
urn:nbn:de:101:1-2023121409253401081967
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yang, Shuang
- Feng, Weineng
- Deng, Yanming
- Liang, Jianmiao
- SpringerLink (Online service)
Other Objects (12)
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report
Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report
Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report
5′ ALK Amplification in Neuroblastoma: A Case Report
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Primary Resistance to ALK Inhibitors in a Patient with Nonsmall Cell Lung Cancer with ALK Rearrangement: A Case Report with Review of Literature
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report
Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report
Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report
5′ ALK Amplification in Neuroblastoma: A Case Report
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Primary Resistance to ALK Inhibitors in a Patient with Nonsmall Cell Lung Cancer with ALK Rearrangement: A Case Report with Review of Literature
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report
Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report
Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report
Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report
5′ ALK Amplification in Neuroblastoma: A Case Report
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer